Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Ligand-analog-irreversible-enzyme-inhibitor-conjugates-and-methods-for-use

 Fungicidal, miticidal and ovicidal alkoxycarbonylalkyl-substituted and carbamylalkyl-substituted N-haloalkylthiosulfonamides
What is claimed is: 1. A compound of the formula ##STR20## wherein R is phenyl substituted with up ...


 Perfluoralkylcyanocyclopropenes
The embodiments of the invention in which an exclusive property or privilege is claimed are defined ...


 Insecticidal esters
We claim: 1. The (+), (-), and (.+-.) forms of the compounds of the general formula I ##STR12## ...


 Insecticidal esters
We claim: 1. The (+), (-) and (.+-.) forms of the compounds of the general formula I ##STR10## ...


 Pesticidal .alpha.-allenyl-3-phenoxybenzyl-2,2-dimethyl-3-(2,2-dihalovinyl)-cyclopr opane-1-carboxylates
What is claimed is: 1. A cyclopropanecarboxylic acid .alpha.-allenyl-3-phenoxybenzyl ester of the ...


 Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
I claim: 1. A method for increasing the growth rate of meat-producing animals and improving the ...


 Tertiary aromatic amine accelerators in acrylic resin
OF INVENTION The tertiary aromatic amines employed in the present invention may be used ...


 Phenolic derivative
The following examples more fully illustrate the preparation of the compounds of the invention. A...


 Method for contraception by the administration of sequential contraceptive preparations
What is claimed is: 1. A method of contraception wherein a combination of an estrogen and a ...


 Male contraceptive and method of achieving male contraception
I claim: 1. A method of immunization of human males to achieve contraception which includes the ...


 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Details
Inventors: Voss, Houston F.; Plattner, Jacob; Herrin, Thomas R.;
Assignee: Abbott Laboratories (North Chicago, IL)
Primary Examiner: Wiseman; Thomas G.
Assistant Examiner:
Attorney, Agent or Firm: McDonnell; John J.

The present invention encompasses a method for determining ligands in test samples comprising intermixing with the test sample a ligand analog-irreversible enzyme inhibitor conjugate and a binding protein bindable to the ligand and the ligand analog-irreversible enzyme inhibitor conjugate and wherein the amount of ligand analog-irreversible enzyme inhibitor conjugate bound by the binding protein is related to the amount of ligand in the test sample, said binding protein inactivating the irreversible enzyme inhibitor when bound to the ligand analog portion of the conjugate; intermixing an enzyme which is irreversibly inhibited by the ligand analog-irreversible enzyme inhibitor conjugate unbound by the binding protein; and intermixing substrate to the enzyme and monitoring the enzyme substrate reaction. The invention also includes ligand analog-irreversible enzyme inhibitor conjugates useful as reagents in practicing the method. Methods and reagents of the present are particularly useful in determining drugs, hormones, and the like in biological fluids.

DETAILED DESCRIPTION OF THE INVENTION The present invention relates to methods and reagents for determining ligands in biological fluids such as serum, plasma, spinal fluid, amnionic fluid and urine.
The term ligand as used in the present invention refers to haptens, polypeptides, proteins, and glycoproteins having molecular weights generally below 150,000.
Haptens are protein-free bodies, generally of low molecular weight that do not induce antibody formation when injected into an animal, but are reactive to antibodies.
Antibodies to hapten are raised by first conjugating the hapten to a protein and injecting the conjugate product into an animal or human.
The resulting antibodies are isolated by conventional antibody isolation techniques.
For purposes of the present invention, the antibodies should be substantially free of serum protein materials such as indicator enzymes used in the test or inhibitors to antibody binding.
These are conveniently removed by ion exchange chromatography on an anion exchange column or other suitable protein separation technique.
Representative ligands determinable by methods of the present invention are steroids such as estrone, estradiol, cortisol, testosterone, progesterone, chenodeoxycholic acid, digoxin, cholic acid, deoxycholic acid, lithocholic acids and the ester and amide derivatives thereof; vitamins such as vitamin B-12, folic acid; thyroxine, triiodothyronine, histamine, serotonin, prostaglandins such as PGE, PGF, PGA; adrenalin, noradrenalin and drugs such as opiates, theophylline, dilantin; barbituates such as phenobarbitol and derivatives thereof and carbamazepins, aminoglycoside antibiotics like gentimycin and tobramycin.
Representative polypeptides and glycoproteins determinable by methods of the present invention are insulin, platelet factor 4 and polypeptide determinants of large antigens.
Ligand analogs are functional or functionalized ligands suitable for conjugation to irreversible enzyme inhibitors.
Acids, esters, amides, amines, hydroxy, isocyanate, isothiocyanate are suitable functional groups



Related patents
  Rapid assaying method for guanase
What we claimed is: 1. In the method of assaying guanase in the sample of the body fluid by adding guanine to said sample whereby said guanine is changed to xanthine, ...
  Method and mixture for producing an artificial skiing track
What is claimed is: 1. In a method for producing an artificial track for skiing in all seasons, the step consisting of covering the ground area which is to form the ...
  Method for simultaneously monitoring turnover rate in multiple proteins
The invention provides an assay method for cellular and extracellular protein biodynamics comprising the use of radiochemical techniques in combination with high ...
  Immunoassays using support-containing separate antigens and antibodies derived from an immune complex
What is claimed is: 1. A process for the detection of an antigen in a specimen which process comprises: (a) contacting said specimen with a substrate having bound ...
  Bile acid sulfate sulfatase, process for its preparation and method for assaying bile acid
We claim: 1. A method for the preparation of bile acid sulfate sulfatase comprising the steps of culturing Pseudomonas testosteroni in a culture medium containing bile ...
  Processes for producing glucan using Elsinoe
The object of the present invention is to develop a new glucan which is utilizable not only in the food and pharmaceutical industries but also in other various ...
  Sustained release polymers
I claim: 1. A water soluble copolymer consisting essentially of from 20 to 60 parts of at least one member selected from the class consisting of acrylic acid and ...
  Vaccine compositions
OF THE INVENTION Target cells are inactivated by treatment with psoralens and irradiation with LWUV. Target cells refer to normal cells or virus-infective cells which ...
  Cyanobenzyl cyclopropane carboxylate pesticides
We claim: 1. A method of combating insect or acarid pests at a locus which comprises applying to the locus a pesticidally effective amount of a cyanobenzyl cyclopropane ...
  Aqueous flowable concentrates of particulate water-insoluble pesticides
What is claimed is: 1. A flowable, viscous, aqueous pesticidal concentrate which is compatible with other pesticides on dilution with water consisting essentially of ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved